Clinical studies powering a
new era in
early cancer detection
Our clinical research program drives discovery and validation of our early cancer detection tests through rigorous methods and partnerships with leading academic and health organizations.
Our clinical studies
Status: Recruitment complete
Status: Recruiting
Our colorectal cancer screening study: PREEMPT CRC®
PREEMPT CRC is the largest clinical study validating a blood-based colorectal screening test. With more than 200 study sites across urban and rural communities, PREEMPT CRC locations included community hospitals, health systems, private clinics, tertiary centers and teaching hospitals. PREEMPT CRC completed study enrollment in May 2022.
Driving representation in clinical studies
At Freenome, we're committed to recruiting a diverse population for our clinical studies. PREEMPT CRC was designed to be representative of the population and enrolled participants from every state in the continental United States. More than 30,000 participants enrolled and completed the study with a range of racial, ethnic, and socioeconomic backgrounds.
LEARN MORE ABOUT PREEMPT CRCLearn more about our work with Morehouse School of Medicine to drive diverse enrollment in PREEMPT CRC
See Poster
Our multi-cancer early detection studies
We are extending our multiomics platform beyond colorectal cancer to screen for other cancers as part of our multi-cancer clinical program.
We are currently enrolling participants with and without cancer in two large studies as part of our multi-cancer research program:
The Vallania Study is Freenome’s clinical study for the refinement and further development of a test to detect multiple cancers.
Learn more about The Vallania Study
The Sanderson Study is Freenome’s first study for the detection of multiple cancers that pairs multiomics with real-world data and is designed to bridge clinical research with day-to-day clinical impact.
Learn more about The Sanderson StudyIn honor of the patients we know and love
At Freenome, we are scientists, technologists, and innovators, but most importantly we are people. Our own experiences with cancer drive the work we do. That’s why Freenome’s discovery studies are named for employees’ loved ones who battled cancer.
The Vallania Study is named in honor of Natalina Vallania, the loving mother of a Freenome scientist.
The Sanderson Study is named in honor of Tim Sanderson, the loving father of a Freenome engineer.